Literature DB >> 30240784

Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Clarissa D Staton1, Jazmine D W Yaeger1, Delan Khalid2, Fadi Haroun3, Belissa S Fernandez4, Jessica S Fernandez4, Bali K Summers5, Tangi R Summers1, Monica Sathyanesan6, Samuel S Newton6, Cliff H Summers7.   

Abstract

Knockdown of orexin/hypocretin 2 receptor (Orx2) in the basolateral amygdala (BLA) affects anxious and depressive behavior. We use a new behavioral paradigm, the Stress Alternatives Model (SAM), designed to improve translational impact. The SAM induces social stress in adult male mice by aggression from larger mice, allowing for adaptive decision-making regarding escape. In this model, mice remain (Stay) in the oval SAM arena or escape from social aggression (Escape) via routes only large enough for the smaller mouse. We hypothesized intracerebroventricular (icv) stimulation of Orx2 receptors would be anxiolytic and antidepressive in SAM-related social behavior and the Social Interaction/Preference (SIP) test. Conversely, we predicted that icv antagonism of Orx2 receptors would promote anxious and depressive behavior in these same tests. Anxious behaviors such as freezing (both cued and conflict) and startle are exhibited more often in Stay compared with Escape phenotype mice. Time spent attentive to the escape route is more frequent in Escape mice. In Stay mice, stimulation of Orx2 receptors reduces fear conditioning, conflict freezing and startle, and promotes greater attention to the escape hole. This anxiolysis was accompanied by activation of a cluster of inhibitory neurons in the amygdala. A small percentage of those Stay mice also begin escaping; whereas Escape is reversed by the Orx2 antagonist. Escape mice were also Resilient, and Stay mice Susceptible to stress (SIP), with both conditions reversed by Orx2 antagonism or stimulation respectively. Together, these results suggest that the Orx2 receptor may be a useful potential target for anxiolytic or antidepressive therapeutics.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Anxiety; Defeat; Depression; Fear conditioning; Freezing; Hypocretin; MK-1064, 5″-chloro-N-[(5,6-dimethoxy-2-pyridinyl)methyl]-[2,2':5′,3″-terpyridine]-3′-carboxamide - an Orx(2) antagonist; Resilience; Startle; Stress Alternatives Model; Susceptibility; [Ala11, d-Leu15]–Orx(B), a modified Orx(B) peptide used as an Orx(2) receptor agonist

Mesh:

Substances:

Year:  2018        PMID: 30240784      PMCID: PMC6275094          DOI: 10.1016/j.neuropharm.2018.09.016

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  102 in total

Review 1.  Hypothalamic regulation of sleep and circadian rhythms.

Authors:  Clifford B Saper; Thomas E Scammell; Jun Lu
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

2.  Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems.

Authors:  C Broberger; L De Lecea; J G Sutcliffe; T Hökfelt
Journal:  J Comp Neurol       Date:  1998-12-28       Impact factor: 3.215

3.  Role of the orexin (hypocretin) system in contextual fear conditioning in rats.

Authors:  Huiying Wang; Sa Li; Gilbert J Kirouac
Journal:  Behav Brain Res       Date:  2016-08-26       Impact factor: 3.332

4.  Increased anxiety but normal fear and safety learning in orexin-deficient mice.

Authors:  Radwa Khalil; Markus Fendt
Journal:  Behav Brain Res       Date:  2016-12-10       Impact factor: 3.332

5.  Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.

Authors:  Joanne S Allard; Yousef Tizabi; James P Shaffery; C Ovid Trouth; Kebreten Manaye
Journal:  Neuropeptides       Date:  2004-10       Impact factor: 3.286

Review 6.  Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation.

Authors:  J Haller; M Aliczki; K Gyimesine Pelczer
Journal:  Neurosci Biobehav Rev       Date:  2012-09-12       Impact factor: 8.989

7.  Learning strategies during fear conditioning.

Authors:  Russ E Carpenter; Cliff H Summers
Journal:  Neurobiol Learn Mem       Date:  2009-05       Impact factor: 2.877

8.  Neuropeptide S and BDNF gene expression in the amygdala are influenced by social decision-making under stress.

Authors:  Justin P Smith; Justin K Achua; Tangi R Summers; Patrick J Ronan; Cliff H Summers
Journal:  Front Behav Neurosci       Date:  2014-04-08       Impact factor: 3.558

9.  Putting the "Biology" Back into "Neurobiology": The Strength of Diversity in Animal Model Systems for Neuroscience Research.

Authors:  Joyce Keifer; Cliff H Summers
Journal:  Front Syst Neurosci       Date:  2016-08-22

10.  Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations.

Authors:  África Flores; Cyril Herry; Rafael Maldonado; Fernando Berrendero
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

View more
  15 in total

1.  Contextual generalization of social stress learning is modulated by orexin receptors in basolateral amygdala.

Authors:  Jazmine D W Yaeger; Kevin T Krupp; Tangi R Summers; Cliff H Summers
Journal:  Neuropharmacology       Date:  2022-06-17       Impact factor: 5.273

2.  Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents.

Authors:  Octavian Vasiliu
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

Review 3.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

Review 4.  Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.

Authors:  Ying Han; Kai Yuan; Yongbo Zheng; Lin Lu
Journal:  Neurosci Bull       Date:  2019-11-28       Impact factor: 5.203

Review 5.  Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.

Authors:  Cliff H Summers; Jazmine D W Yaeger; Clarissa D Staton; David H Arendt; Tangi R Summers
Journal:  Brain Res       Date:  2018-12-24       Impact factor: 3.252

Review 6.  Evolution of stress responses refine mechanisms of social rank.

Authors:  Wayne J Korzan; Cliff H Summers
Journal:  Neurobiol Stress       Date:  2021-04-21

Review 7.  Cardinal role of the environment in stress induced changes across life stages and generations.

Authors:  Terence Y Pang; Jazmine D W Yaeger; Cliff H Summers; Rupshi Mitra
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

8.  Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior.

Authors:  Jazmine D W Yaeger; Kevin T Krupp; Benjamin M Jacobs; Benard O Onserio; Brandon L Meyerink; Jacob T Cain; Patrick J Ronan; Kenneth J Renner; Ralph J DiLeone; Cliff H Summers
Journal:  Biol Psychiatry       Date:  2022-01-19       Impact factor: 12.810

Review 9.  Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.

Authors:  George Anderson; Moses Rodriguez; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

Review 10.  Harnessing the Neurobiology of Resilience to Protect the Mental Well-Being of Healthcare Workers During the COVID-19 Pandemic.

Authors:  Ravi Philip Rajkumar
Journal:  Front Psychol       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.